1,031 companies
RYZB
RayzeBio Inc.
RayzeBio is a clinical-stage radiopharmaceutical therapeutics (“RPT”) company with an innovation-leading position in actinium-based RPTs and a pipeline of potentially first-in-class and best-in-class drug development programs.
California
$3,709.0 mm
NASDAQ
RARE
Ultragenyx Pharmaceutical Inc.
ultragenyx is a clinical-stage biotechnology company committed to bringing to market novel products for the treatment of rare and ultra-rare diseases, with an initial focus on serious, debilitating metabolic genetic diseases.
California
$3,659.8 mm
NASDAQ
ARWR
Arrowhead Pharmaceuticals Inc.
arrowhead pharmaceuticals is a clinical stage, nasdaq listed (ticker arwr) company developing medicines that treat intractable diseases by silencing the genes that cause them.
California
$3,624.8 mm
NASDAQ
FOLD
Amicus Therapeutics Inc
amicus therapeutics is a global, patient-centric biotechnology company focused on discovering, developing and delivering novel high-quality medicines for people living with rare metabolic diseases.
Pennsylvania
$3,527.7 mm
NASDAQ
MLTX
MoonLake Immunotherapeutics - Ordinary Shares
moonlake immunotherapeutics ag is a clinical-stage biopharmaceutical company leveraging revolutionary nanobody® technology to develop next-level medicines for immunologic diseases, including inflammatory skin and joint diseases.
Switzerland
$3,209.2 mm
NASDAQ
DRNA
Dicerna Pharmaceuticals Inc
Dicerna Pharmaceuticals, Inc.
Massachusetts
$2,986.1 mm
NASDAQ
PBH
Prestige Consumer Healthcare Inc
at prestige brands, now prestige consumer healthcare, we focus on product innovation and quality in over-the-counter healthcare products to improve the lives of our customers worldwide.
New York
$2,953.8 mm
NYSE
BHC
Bausch Health Companies Inc
bausch health companies inc.
Quebec, Canada
$2,942.1 mm
NYSE
KDNY
Chinook Therapeutics Inc
chinook therapeutics (nasdaq: kdny) is a clinical-stage biotechnology company developing precision medicines for kidney diseases.
Washington
$2,900.2 mm
NASDAQ
XENE
Xenon Pharmaceuticals Inc
xenon® (nasdaq: xene) is a biopharmaceutical company focused on the development of novel medicines through the application of our proprietary discovery platform, which we refer to as extreme genetics.
British Columbia, Canada
$2,864.5 mm
NASDAQ
CBAY
Cymabay Therapeutics Inc
cymabay therapeutics is a clinical-stage biopharmaceutical company located in the san francisco bay area focused on developing therapies to treat metabolic diseases with high unmet medical need or serious rare and orphan diseases.
California
$2,778.3 mm
NASDAQ
IDYA
Ideaya Biosciences Inc
ideaya biosciences is an oncology-focused biotechnology company committed to the discovery of personalized synthetic lethality medicines targeting dna damage and repair for genetically defined patient populations and immuno-oncology therapies targeting the tumor microenvironment.
California
$2,644.1 mm
NASDAQ
AMPH
Amphastar Pharmaceuticals Inc
amphastar pharmaceuticals, inc., headquartered in rancho cucamonga, california, established in 1996, is a recognized specialty pharmaceutical company that uses state-of-the-art, cgmp compliant facilities to develop, manufacture, and market injectable and inhalation products.
California
$2,638.7 mm
NASDAQ
MYOV
Myovant Sciences Ltd
Myovant Sciences aspires to redefine care for women and for men through purpose-driven science, empowering medicines, and transformative advocacy.
United Kingdom
$2,623.4 mm
NYSE
SMMT
Summit Therapeutics Inc
summit is a uk company focused on the discovery and development of novel drug candidates to treat areas of high unmet medical need.
California
$2,530.0 mm
NASDAQ
CORT
Corcept Therapeutics Inc
leading the field in the discovery of drugs that modulate the effects of cortisol the adverse effects of excess cortisol have been corcept’s focus since the company’s inception.
California
$2,516.2 mm
NASDAQ
HCM
HUTCHMED (China) Limited
HUTCHMED China Ltd, formerly Hutchison China Meditech Ltd, is an investment holding company principally engaged in the manufacturing and sale of drugs.
Hong Kong
$2,484.8 mm
NASDAQ
GLPG
Galapagos NV
Galapagos NV is a clinical-stage biotechnology company specialized in the discovery and development of small molecule medicines with novel modes of action.
Belgium
$2,483.0 mm
NASDAQ
RYTM
Rhythm Pharmaceuticals Inc.
rhythm pharmaceuticals inc.
Massachusetts
$2,422.3 mm
NASDAQ
CRNX
Crinetics Pharmaceuticals Inc
neuropeptide receptor targeted therapeutics for the treatment of endocrine diseases and cancers.
California
$2,371.4 mm
NASDAQ